Crossject

ISIN: FR0011716265 | Ticker: ALCJ | LEI: 969500W1VTFNL2D85A65

Sector: Health Care – Sub-Industry: Health Care Equipment

Country: France

About Crossject

Company Description

Crossject is revolutionizing the administration of well-established, clinically-proven treatments and bringing unprecedented advantages to patients with its innovative, needle-free auto-injector ZENEO®.
ZENEO® is no less than 12 years of R&D and more than 400 obtained patents.

Currently, 8 treatments are in advanced stages of development, which 7 for emergency situations.
With its unique know-how, Crossject aims to become a world leader in the self-administration of emergency needle free injectables.

Year founded

2001

Served area

Worldwide

Headcount

100

Headquarters

Parc Mazen-Sully 6 Rue Pauline Kergomard, 21000 Dijon – France

Filings & Publications

Insider Trades

Date	Trading entity / Person	Association	Trade type	Volume
06.03.23	None	Other	Other	EUR 75,434.70

Capital markets information

ISIN

FR0011716265

LEI

969500W1VTFNL2D85A65

Sector

Health Care

Industry Group

Health Care Equipment & Services

Industry

Health Care Equipment & Supplies

Sub-Industry

Health Care Equipment

Listed Stock Exchange

Euronext Paris

Main Stock Exchange

View Crossject on stock exchange

Contact Investor Relations department

First name*

Last name*

Your email*

Your phone number

Your company

Your message

I agree to the terms of the privacy policy.*

Stay up to date

Keep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.